InnoCare Pharma’s A- and H-shares rose in tandem; A-shares c
文 / 小金
2026-09-24 13:10:03
来源:亚金网
InnoCare Pharma’s A- and H-shares rose in tandem; A-shares climbed nearly 2% while H-shares turned positive after the company’s wholly owned subsidiary signed a licensing agreement with Eli Lilly that includes up to $3.25 bln in milestone payments.
